These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19210355)

  • 1. The economic impact of severe asthma to low-income families.
    Franco R; Nascimento HF; Cruz AA; Santos AC; Souza-Machado C; Ponte EV; Souza-Machado A; Rodrigues LC; Barreto ML
    Allergy; 2009 Mar; 64(3):478-83. PubMed ID: 19210355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of a state funded programme for control of severe asthma.
    Franco R; Santos AC; do Nascimento HF; Souza-Machado C; Ponte E; Souza-Machado A; Loureiro S; Barreto ML; Rodrigues LC; Cruz AA
    BMC Public Health; 2007 May; 7():82. PubMed ID: 17509137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark--cost-effectiveness analysis based on five randomised controlled trials.
    Wickstrøm J; Dam N; Malmberg I; Hansen BB; Lange P
    Clin Respir J; 2009 Jul; 3(3):169-80. PubMed ID: 20298400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain.
    Quirce S; Barcina C; Plaza V; Calvo E; Muñoz M; Ampudia R; Capel M
    J Asthma; 2011 Oct; 48(8):839-47. PubMed ID: 21942354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation.
    Miller E; FitzGerald JM
    Can J Clin Pharmacol; 2008; 15(2):e165-76. PubMed ID: 18515918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma.
    Sears MR; Boulet LP; Laviolette M; Fitzgerald JM; Bai TR; Kaplan A; Smiljanic-Georgijev N; Lee JS
    Eur Respir J; 2008 May; 31(5):982-9. PubMed ID: 18216054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory therapy reduces total costs of asthma care compared with bronchodilation: the Asthma Outcomes Registry.
    Huse DM; Russell MW; Weiss ST; Hartz SC
    Am J Manag Care; 2000 Sep; 6(9):1045-50. PubMed ID: 11184066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma.
    Sullivan SD; Buxton M; Andersson LF; Lamm CJ; Liljas B; Chen YZ; Pauwels RA; Weiss KB
    J Allergy Clin Immunol; 2003 Dec; 112(6):1229-36. PubMed ID: 14657888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
    Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
    Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life prospective study on asthma control in Italy: cross-sectional phase results.
    Allegra L; Cremonesi G; Girbino G; Ingrassia E; Marsico S; Nicolini G; Terzano C;
    Respir Med; 2012 Feb; 106(2):205-14. PubMed ID: 22035853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.
    Goossens LM; Riemersma RA; Postma DS; van der Molen T; Rutten-van Mölken MP
    Adv Ther; 2009 Sep; 26(9):872-85. PubMed ID: 19768640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study.
    Weiss K; Buxton M; Andersson FL; Lamm CJ; Liljas B; Sullivan SD
    Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():21-7. PubMed ID: 16573705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide.
    Miraglia del Giudice M; Piacentini GL; Capasso M; Capristo C; Maiello N; Boner AL; Capristo AF
    Respir Med; 2007 Aug; 101(8):1809-13. PubMed ID: 17418554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study.
    van Schayck OC; Haughney J; Aubier M; Selroos O; Ekström T; Ostinelli J; Buhl R
    Respir Med; 2012 Feb; 106(2):189-96. PubMed ID: 22119455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
    Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
    N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the cost-effectiveness of budesonide and sodium cromoglycate in the management of childhood asthma in everyday clinical practice.
    Andersson F; Kjellman M; Forsberg G; Möller C; Arheden L
    Ann Allergy Asthma Immunol; 2001 May; 86(5):537-44. PubMed ID: 11379805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of disease management on outcomes and cost of care: a study of low-income asthma patients.
    Rossiter LF; Whitehurst-Cook MY; Small RE; Shasky C; Bovbjerg VE; Penberthy L; Okasha A; Green J; Ibrahim IA; Yang S; Lee K
    Inquiry; 2000; 37(2):188-202. PubMed ID: 10985112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of asthma therapy: a comprehensive review.
    Domínguez-Ortega J; Phillips-Anglés E; Barranco P; Quirce S
    J Asthma; 2015; 52(6):529-37. PubMed ID: 25539023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.